A detailed history of Xtx Topco LTD transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 292,180 shares of ACET stock, worth $277,571. This represents 0.03% of its overall portfolio holdings.

Number of Shares
292,180
Previous 259,788 12.47%
Holding current value
$277,571
Previous $314,000 33.76%
% of portfolio
0.03%
Previous 0.03%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.07 - $1.63 $34,659 - $52,798
32,392 Added 12.47%
292,180 $420,000
Q2 2024

Aug 12, 2024

BUY
$1.21 - $2.4 $40,824 - $80,973
33,739 Added 14.93%
259,788 $314,000
Q1 2024

May 13, 2024

BUY
$1.76 - $3.45 $357,364 - $700,515
203,048 Added 882.78%
226,049 $531,000
Q4 2023

Feb 13, 2024

SELL
$1.11 - $1.89 $36,194 - $61,629
-32,608 Reduced 58.64%
23,001 $43,000
Q3 2023

Nov 13, 2023

BUY
$1.37 - $3.4 $18,436 - $45,753
13,457 Added 31.92%
55,609 $76,000
Q2 2023

Aug 14, 2023

BUY
$2.13 - $7.13 $66,115 - $221,315
31,040 Added 279.34%
42,152 $102,000
Q1 2023

May 12, 2023

SELL
$5.52 - $9.23 $100,971 - $168,835
-18,292 Reduced 62.21%
11,112 $64,000
Q4 2022

Feb 14, 2023

BUY
$7.72 - $21.27 $226,998 - $625,423
29,404 New
29,404 $262,000

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $38M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.